Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
Hum Pathol
    November 2023
  1. QIJUN C, Wei W, Cheng W, Dongni L, et al
    Clinicopathological features and molecular genetic changes in 17 cases of uterine tumor resembling ovarian sex cord tumor.
    Hum Pathol. 2023 Nov 22:S0046-8177(23)00229.
    >> Share

    September 2023
  2. KOLB S, Hoffmann I, Monje N, Dragomir MP, et al
    LRP1B - a prognostic marker in tubo-ovarian high-grade serous carcinoma.
    Hum Pathol. 2023 Sep 22:S0046-8177(23)00186.
    >> Share

  3. D'ANGELO E, Espinosa I, Felicioni L, Buttitta F, et al
    Ovarian High-grade Serous Carcinoma with Transitional-like (SET) Morphology: A Homologous Recombination-deficient Tumor.
    Hum Pathol. 2023 Sep 4:S0046-8177(23)00185-5. doi: 10.1016/j.humpath.2023.
    >> Share

    March 2023
  4. SIEGMUND SE, Mehra R, Acosta AM
    An update on diagnostic tissue-based biomarkers in testicular tumors.
    Hum Pathol. 2023;133:32-55.
    >> Share

    January 2023
  5. LU B, Xia Y, Chen J, Tang J, et al
    NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: a clinicopathological and molecular study of 18 cases.
    Hum Pathol. 2023 Jan 13:S0046-8177(23)00012.
    >> Share

    October 2022
  6. ZAFAR R, Schrader LJ, Cheville JC, Schoolmeester JK, et al
    A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma.
    Hum Pathol. 2022;128:31-47.
    >> Share

    June 2022
  7. LONDERO AP, Orsaria M, Viola L, Marzinotto S, et al
    Survivin, Sonic hedgehog, Kruppel-like factors, and p53 pathway in serous ovarian cancer: an immunohistochemical study.
    Hum Pathol. 2022 Jun 28. pii: S0046-8177(22)00168.
    >> Share

    May 2022
  8. MCCLUGGAGE WG, Stewart CJR, Belcijan NL, Mourad S, et al
    Neuroectodermal elements are part of the morphological spectrum of DICER1-associated neoplasms.
    Hum Pathol. 2022;123:46-58.
    >> Share

    April 2022
  9. SILVA EG, Lawson BC, Ramalingam P, Liu J, et al
    Precursors in the Ovarian Stroma, Another Pathway to Explain the Origin of Ovarian Serous Neoplasms.
    Hum Pathol. 2022 Apr 12. pii: S0046-8177(22)00087.
    >> Share

    March 2022
  10. ZHANG L, Zhang L, Wang XI, Katz G, et al
    The value of SOX2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
    Hum Pathol. 2022 Mar 21. pii: S0046-8177(22)00070.
    >> Share

    August 2021
  11. VISSER NCM, van der Wurff AAM, IntHout J, Reijnen C, et al
    Improving preoperative diagnosis in endometrial cancer using systematic morphological assessment and a small immunohistochemical panel.
    Hum Pathol. 2021 Aug 18. pii: S0046-8177(21)00148.
    >> Share

  12. SHETTY S, Habeeb O, Rivera C, Astbury C, et al
    MDM2 amplification in malignant Brenner tumors may play a role in progression to malignancy and aid in separation from urothelial and other ovarian carcinomas.
    Hum Pathol. 2021 Aug 12. pii: S0046-8177(21)00141.
    >> Share

    July 2021
  13. SIATECKA H, Masand RP
    Brenner tumor associated with rete ovarii: a histologic and immunohistochemical analysis of six cases exploring the relationship between these entities.
    Hum Pathol. 2021;113:84-91.
    >> Share

    June 2021
  14. LAWSON BC, Yang RK, Euscher ED, Ramalingam P, et al
    TP53 Variant Allele Frequency Correlates with the Chemotherapy Response Score in Ovarian/Fallopian Tube/Peritoneal High-Grade Serous Carcinoma.
    Hum Pathol. 2021 Jun 18. pii: S0046-8177(21)00110.
    >> Share

    April 2021
  15. ZHANG Y, Jeyachandran D, Desouki MM
    Grossly Unremarkable Cervix in Endometrial Carcinomas: LVSI and MELF Pattern may be Associated with High Incidence of Cervical Stromal Involvement.
    Hum Pathol. 2021 Apr 29. pii: S0046-8177(21)00069.
    >> Share

  16. NIU N, Shen W, Zhong Y, Bast RC Jr, et al
    Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas.
    Hum Pathol. 2021 Apr 19. pii: S0046-8177(21)00054.
    >> Share

    December 2020
  17. HALIMI SA, Maeda D, Ushiku-Shinozaki A, Goto A, et al
    Comprehensive immunohistochemical analysis of the gastrointestinal and Mullerian phenotypes of 139 ovarian mucinous cystadenomas.
    Hum Pathol. 2020 Dec 1. pii: S0046-8177(20)30239.
    >> Share

    November 2020
  18. SILVA E, Malpica A, Roma A, Ramalingam P, et al
    Ovarian Mucinous Neoplasms, Intestinal Type, in Premenopausal Patients, Develop in Abnormal Ovaries.
    Hum Pathol. 2020 Nov 20. pii: S0046-8177(20)30231.
    >> Share

    June 2020
  19. ROTH LM, Cheng L
    Gonadoblastoma: origin and outcome.
    Hum Pathol. 2020;100:47-53.
    >> Share

    April 2020
  20. TESSIER-CLOUTIER B, Cochrane DR, Karnezis AN, Colborne S, et al
    Proteomic Analysis of Transitional Cell Carcinoma-Like Variant of Tubo-Ovarian High-Grade Serous Carcinoma.
    Hum Pathol. 2020 Apr 29. pii: S0046-8177(20)30047.
    >> Share

    February 2020
  21. WIEDEMEYER K, Kobel M, Koelkebeck H, Xiao Z, et al
    High GLYPICAN-3 expression Characterizes a Biologically Distinct subset of ovarian clear cell carcinomas in Canadian patients: An Opportunity for targeted Therapy.
    Hum Pathol. 2020 Feb 1. pii: S0046-8177(20)30015.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016